Par Drugs And Chemicals Limited (PAR) — Cash Flow-to-Debt Ratio
Par Drugs And Chemicals Limited (PAR) has a Cash Flow-to-Debt Ratio of 0.38x as of September 2025, meaning its operating cash flow of Rs80.95 Million could theoretically repay 0% of its total liabilities (Rs210.91 Million) in one year. See financial flexibility index of Par Drugs And Chemicals Limited to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Par Drugs And Chemicals Limited Cash Flow-to-Debt Ratio (2016–2026)
Historical debt coverage capacity for Par Drugs And Chemicals Limited across 11 annual periods. For the full cash flow conversion analysis, see PAR cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Par Drugs And Chemicals Limited (2016–2026)
Year-by-year debt coverage analysis for Par Drugs And Chemicals Limited. Check how high is Par Drugs And Chemicals Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | 0.95x | Rs164.32 Million | Rs172.28 Million | ▲ +20.5% |
| 2025 | 0.79x | Rs161.60 Million | Rs204.15 Million | ▼ -37.5% |
| 2024 | 1.27x | Rs202.49 Million | Rs159.79 Million | ▲ +67.0% |
| 2023 | 0.76x | Rs133.77 Million | Rs176.30 Million | ▲ +87.5% |
| 2022 | 0.40x | Rs76.15 Million | Rs188.13 Million | ▼ -19.0% |
| 2021 | 0.50x | Rs120.85 Million | Rs241.70 Million | ▲ +26.8% |
| 2020 | 0.39x | Rs76.91 Million | Rs195.01 Million | ▲ +15.8% |
| 2019 | 0.34x | Rs75.77 Million | Rs222.38 Million | ▲ +162.3% |
| 2018 | 0.13x | Rs43.18 Million | Rs332.40 Million | ▼ -47.8% |
| 2017 | 0.25x | Rs91.72 Million | Rs368.38 Million | ▲ +55.2% |
| 2016 | 0.16x | Rs65.27 Million | Rs406.75 Million | — |